Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 29.3 -0.44 (-1.48%) Market Cap: 789.10 Mil Enterprise Value: 544.21 Mil PE Ratio: 0 PB Ratio: 2.99 GF Score: 84/100

Arcturus Therapeutics Holdings Inc. - Special Call Transcript

Dec 28, 2020 / 09:30PM GMT
Release Date Price: $92.42 (-5.82%)
Operator

Greetings, and welcome to Arcturus Therapeutics Conference Call. (Operator Instructions) Please note this conference is being recorded. I would now like to turn the conference over to your host, Neda Safarzadeh, Senior Director and Head of Investor Relations, Public Relations and Marketing at Arcturus Therapeutics. You may begin.

Neda Safarzadeh;Public Relations;Marketing
Arcturus Therapeutics Holdings Inc. - Sr. Director and Head of IR

/&

Thank you, operator, and good afternoon, everyone. We are joined today by Joseph Payne, President and CEO; Andy Sassine, CFO; Dr. Pad Chivukula, CFO and COO; Dr. Steve Hughes, Chief Development Officer; and Professor Ooi Eng Eong, emerging infectious diseases program at Duke-NUS Medical School and a member of Arcturus' vaccine Platform Scientific Advisory Board.

Before we begin, I would like to remind everyone that except for statements of historical facts, the statements made by management and any responses to questions on this conference call constitute forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot